TELA Bio, Inc. (TELA)Healthcare | Medical Devices | Malvern, United States | NasdaqGM
0.70 USD
+0.05
(7.692%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.70 |
Hot Take ↕ | Aug. 22, 2026, 5:10 a.m. EDT
TELA Bio presents a classic value trap with deteriorating fundamentals and a catastrophic multi-year price trajectory. The business is bleeding cash, with negative free cash flow and operating margins, while revenue contracted by 4.5% recently. The stock has lost over 87% of its value over the last five years, driven by a brutal sequence of declines including a nearly 68% drop in 2024 and another 38% fall in 2025. Despite the analyst 'Buy' rating and a lofty $2.10 price target, the market has clearly priced out the business due to its inability to generate value or grow top-line sales. The recent price action confirms this bearish sentiment, with the stock trading well below its 50-day and 200-day moving averages and failing to recover from recent lows. While options traders are dreaming of a rebound to the $2.50–$5.00 range, the absence of any put protection suggests this is a one-way speculative bet on a turnaround that the balance sheet and cash burn cannot currently support. This is not a setup for a high-conviction entry; it is a speculative gamble on a company that is currently failing to execute. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.137952 |
| AutoETS | 0.139868 |
| MSTL | 0.146472 |
| AutoTheta | 0.333760 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 28% |
| H-stat | 10.42 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.274 |
| Excess Kurtosis | -1.14 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 1.509 |
| Market Cap | 31,426,328 |
| Forward P/E | -1.34 |
| Beta | 1.36 |
| Profit Margins | -51.53% |
| Website | https://www.telabio.com |
As of Aug. 22, 2026, 5:10 a.m. EDT: Speculators are positioning exclusively for upside moves, evidenced by significant open interest in out-of-the-money calls at strikes of $2.50 and $5.00 across multiple expirations. There is zero put activity recorded, indicating a lack of hedging or bearish bets. However, the implied volatility is effectively zero, suggesting these contracts are illiquid or stale, and the positioning represents speculative hope rather than a robust consensus.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.62643677 |
| Address1 | 1 Great Valley Parkway |
| Address2 | Suite 24 |
| All Time High | 23.545 |
| All Time Low | 0.501 |
| Ask | 1.18 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Analyst Rating | 1.6 - Buy |
| Average Daily Volume10 Day | 346,560 |
| Average Daily Volume3 Month | 150,112 |
| Average Volume | 150,112 |
| Average Volume10Days | 346,560 |
| Beta | 1.361 |
| Bid | 0.658 |
| Bid Size | 2 |
| Board Risk | 9 |
| Book Value | -0.354 |
| City | Malvern |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 10 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.7 |
| Current Ratio | 2.991 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 0.7 |
| Day Low | 0.6501 |
| Display Name | TELA Bio |
| Earnings Call Timestamp End | 1,786,393,800 |
| Earnings Call Timestamp Start | 1,786,393,800 |
| Earnings Timestamp | 1,786,392,000 |
| Earnings Timestamp End | 1,794,513,600 |
| Earnings Timestamp Start | 1,794,513,600 |
| Ebitda | -33,008,000 |
| Ebitda Margins | -0.41307998 |
| Enterprise To Ebitda | -1.785 |
| Enterprise To Revenue | 0.737 |
| Enterprise Value | 58,918,328 |
| Eps Current Year | -0.7 |
| Eps Forward | -0.522 |
| Eps Trailing Twelve Months | -0.77 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.74752 |
| Fifty Day Average Change | -0.04752004 |
| Fifty Day Average Change Percent | -0.06357026 |
| Fifty Two Week Change Percent | -62.643677 |
| Fifty Two Week High | 1.87 |
| Fifty Two Week High Change | -1.1700001 |
| Fifty Two Week High Change Percent | -0.62566847 |
| Fifty Two Week Low | 0.501 |
| Fifty Two Week Low Change | 0.199 |
| Fifty Two Week Low Change Percent | 0.3972056 |
| Fifty Two Week Range | 0.501 - 1.87 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,573,223,400,000 |
| Float Shares | 21,491,569 |
| Forward Eps | -0.522 |
| Forward P E | -1.3409961 |
| Free Cashflow | -17,713,250 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 218 |
| Fullday Change | 0.05 |
| Fullday Change Percent | 7.69231 |
| Fullday Price | 0.7 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.68287003 |
| Gross Profits | 54,567,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.088719994 |
| Held Percent Institutions | 0.65911 |
| Implied Shares Outstanding | 44,894,757 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. |
| Long Name | TELA Bio, Inc. |
| Market | us_market |
| Market Cap | 31,426,328 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_225019977 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -41,179,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 29,181,592 |
| Number Of Analyst Opinions | 5 |
| Open | 0.668 |
| Operating Cashflow | -31,140,000 |
| Operating Margins | -0.48121 |
| Overall Risk | 10 |
| Payout Ratio | 0.0 |
| Phone | 484 320 2930 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 0.7 |
| Post Market Time | 1,787,947,805 |
| Previous Close | 0.65 |
| Price Eps Current Year | -1.0 |
| Price Hint | 4 |
| Price To Book | -1.9774011 |
| Price To Sales Trailing12 Months | 0.39328137 |
| Profit Margins | -0.51533 |
| Quick Ratio | 2.199 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.6 |
| Region | US |
| Regular Market Change | 0.05 |
| Regular Market Change Percent | 7.69231 |
| Regular Market Day High | 0.7 |
| Regular Market Day Low | 0.6501 |
| Regular Market Day Range | 0.6501 - 0.7 |
| Regular Market Open | 0.668 |
| Regular Market Previous Close | 0.65 |
| Regular Market Price | 0.7 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 124,082 |
| Return On Assets | -0.33403 |
| Revenue Growth | -0.045 |
| Revenue Per Share | 1.509 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 44,894,757 |
| Shares Percent Shares Out | 0.0075 |
| Shares Short | 338,486 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 361,787 |
| Short Name | TELA Bio, Inc. |
| Short Percent Of Float | 0.0109 |
| Short Ratio | 2.67 |
| Source Interval | 15 |
| State | PA |
| Symbol | TELA |
| Target High Price | 3.0 |
| Target Low Price | 1.0 |
| Target Mean Price | 2.1 |
| Target Median Price | 2.0 |
| Total Cash | 30,424,000 |
| Total Cash Per Share | 0.678 |
| Total Debt | 57,916,000 |
| Total Revenue | 79,908,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.77 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.875475 |
| Two Hundred Day Average Change | -0.175475 |
| Two Hundred Day Average Change Percent | -0.20043406 |
| Type Disp | Equity |
| Volume | 124,082 |
| Website | https://www.telabio.com |
| Zip | 19,355 |